Multiple Sclerosis Clinical Trials in Los Angeles

Showing 341-360 of 489 trials

Intravenous BI 6727 (Volasertib) in 2nd Line Treatment of Urothelial Cancer

NCT01023958

The primary objective of this trial is to evaluate the efficacy and safety of BI 6727 in patients with locally advanced, metastatic or recurrent urothelial cancer after failure of first line or adjuvant/neoadjuvant chemotherapy.

Neoplasms

Boehringer Ingelheim50 participantsStarted Nov 2009

Beverly Hills, California, United States • Los Angeles, California, United States • Miami, Florida, United States +18 more locations

TERMINATEDPhase 3< 1 mile

Colorectal Cancer Treated With Adjuvant Regorafenib Versus Placebo After Curative Treatment of Liver Metastases in a Randomized, Double-blind, Placebo-Controlled Phase-III STudy

NCT01939223

To evaluate and compare the efficacy and safety of regorafenib versus placebo in subjects with colorectal cancer (CRC) after curative resection of liver metastasis and completion of all planned chemotherapy.

Colorectal Neoplasms

Bayer25 participantsStarted Dec 2013

Laguna Hills, California, United States • Los Angeles, California, United States • Los Angeles, California, United States +118 more locations

Intravenous BI 6727 (Volasertib) in 2nd Line Treatment of Urothelial Cancer

Colorectal Cancer Treated With Adjuvant Regorafenib Versus Placebo After Curative Treatment of Liver Metastases in a Randomized, Double-blind, Placebo-Controlled Phase-III STudy

Multiple Sclerosis Trials in Other Cities

Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors

ARI103094-Follow-Up Study for REDUCE Study Subjects

An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab

Building Resiliency and Increasing Community Hope

Atorvastatin (Lipitor) Therapy in Patients With Clinically Isolated Syndrome (CIS) at Risk for Multiple Sclerosis

Natalizumab Re-Initiation of Dosing

Assessing the Suitability of an Imaging Probe for Use in Clinical Cell and Gene Therapy Trials in Cancer and Rheumatoid Arthritis

Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer

Phase 4 Gastrointestinal Tolerability Study of Dimethyl Fumarate in Patients With Relapsing Forms of Multiple Sclerosis in the United States

Circulating Tumor DNA in Patients at High Risk for Lung Cancer

An Extension Study of RO5045337 in Participants Participating in Previous Roche-sponsored Cancer Studies

This Was an Open-label, Single-arm Extension Study (CFTY720D2306E1) to a Double-blind, Randomized Multicenter, Placebo-controlled, Parallel-group Core Study (CFTY720D2306) in PPMS.

Bone Graft Materials Observational Registry

Combination Study Of SB-485232 (Interleukin 18) And Doxil For Advanced Stage Epithelial Ovarian Cancer

Safety and Efficacy of ADS-5102 in Patients With Multiple Sclerosis and Walking Impairment

Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

Study of LY2784544 Testing Alternative Dosing in Participants With Myeloproliferative Neoplasms

A Study of Vemurafenib in Participants With BRAF V600 Mutation-Positive Cancers

Other Conditions in Los Angeles